367 related articles for article (PubMed ID: 18684282)
81. Psychological distress and mortality in systolic heart failure.
Pelle AJ; Pedersen SS; Schiffer AA; Szabó B; Widdershoven JW; Denollet J
Circ Heart Fail; 2010 Mar; 3(2):261-7. PubMed ID: 20071656
[TBL] [Abstract][Full Text] [Related]
82. Association of psychiatric history and type D personality with symptoms of anxiety, depression, and health status prior to ICD implantation.
Starrenburg AH; Kraaier K; Pedersen SS; van Hout M; Scholten M; van der Palen J
Int J Behav Med; 2013 Sep; 20(3):425-33. PubMed ID: 22821676
[TBL] [Abstract][Full Text] [Related]
83. Effects of an alert system on implantable cardioverter defibrillator-related anxiety: rationale, design, and endpoints of the PANORAMIC multicentre trial.
Duru F; Dorian P; Favale S; Perings C; Pedersen SS; Willems V;
Europace; 2010 May; 12(5):726-30. PubMed ID: 20207746
[TBL] [Abstract][Full Text] [Related]
84. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.
Schefer T; Wolber T; Binggeli C; Holzmeister J; Brunckhorst C; Duru F
Europace; 2008 Sep; 10(9):1052-9. PubMed ID: 18687703
[TBL] [Abstract][Full Text] [Related]
85. [Clinical significance of stress reactivity for frequency of electric shock discharges in patients with implanted cardioverter-defibrillators].
Klein T; Schonecke O; Wollny H; König J; Fries R
Dtsch Med Wochenschr; 2004 Oct; 129(43):2291-4. PubMed ID: 15483767
[TBL] [Abstract][Full Text] [Related]
86. Trajectories of patient-reported health status in patients with an implantable cardioverter defibrillator.
Mastenbroek MH; Denollet J; Versteeg H; van den Broek KC; Theuns DA; Meine M; Zijlstra WP; Pedersen SS
Am J Cardiol; 2015 Mar; 115(6):771-7. PubMed ID: 25623734
[TBL] [Abstract][Full Text] [Related]
87. Psychosocial considerations for children and young adolescents with implantable cardioverter defibrillators: an update.
Sears SF; St Amant JB; Zeigler V
Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S80-2. PubMed ID: 19602170
[TBL] [Abstract][Full Text] [Related]
88. Implantable cardioverter defibrillators and their role in heart failure progression.
Cevik C; Perez-Verdia A; Nugent K
Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
[TBL] [Abstract][Full Text] [Related]
89. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
Daubert JP; Winters SL; Subacius H; Berger RD; Ellenbogen KA; Taylor SG; Schaechter A; Howard A; Kadish A;
Pacing Clin Electrophysiol; 2009 Jun; 32(6):755-61. PubMed ID: 19545338
[TBL] [Abstract][Full Text] [Related]
90. Do implantable cardioverter defibrillators contribute to new depression or anxiety symptoms? A retrospective study.
Amiaz R; Asher E; Rozen G; Czerniak E; Glikson M; Weiser M
Int J Psychiatry Clin Pract; 2016; 20(2):101-5. PubMed ID: 27052573
[TBL] [Abstract][Full Text] [Related]
91. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
Albert CM; Quigg R; Saba S; Estes NA; Shaechter A; Subacius H; Howard A; Levine J; Kadish A;
Am Heart J; 2008 Aug; 156(2):367-72. PubMed ID: 18657670
[TBL] [Abstract][Full Text] [Related]
92. [The quality of life after the implantation of a cardioverter/defibrillator in malignant arrhythmias].
Lüderitz B; Jung W; Deister A; Marneros A; Manz M
Dtsch Med Wochenschr; 1993 Mar; 118(9):285-9. PubMed ID: 8444109
[TBL] [Abstract][Full Text] [Related]
93. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
[TBL] [Abstract][Full Text] [Related]
94. Psychological distress in patients with ICD recall.
Cuculi F; Herzig W; Kobza R; Erne P
Pacing Clin Electrophysiol; 2006 Nov; 29(11):1261-5. PubMed ID: 17100681
[TBL] [Abstract][Full Text] [Related]
95. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.
Hreybe H; Razak E; Saba S
Pacing Clin Electrophysiol; 2007 Sep; 30(9):1091-5. PubMed ID: 17725751
[TBL] [Abstract][Full Text] [Related]
96. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
97. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial.
Chevalier P; Cottraux J; Mollard E; Sai N; Brun S; Burri H; Restier L; Adeleine P
Am Heart J; 2006 Jan; 151(1):191. PubMed ID: 16368316
[TBL] [Abstract][Full Text] [Related]
98. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
[TBL] [Abstract][Full Text] [Related]
99. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II.
Piotrowicz K; Noyes K; Lyness JM; McNitt S; Andrews ML; Dick A; Hall WJ; Moss AJ; Zareba W
Eur Heart J; 2007 Mar; 28(5):601-7. PubMed ID: 17296625
[TBL] [Abstract][Full Text] [Related]
100. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
